AAVs in Retinal Gene Therapy
Type
Blog Post
Published
July 31, 2018, 12:55 p.m.
...limelight. On December 19, 2017 the FDA approved Luxturna™ the first gene therapy for the treatment of a...obtain FDA approval and make history in the form of Luxturna™.
A better vector for ocular gene therapy: Adeno-Associated... first identified serotype and the one used in Luxturna™, can efficiently transduce various types of retinal...some will hopefully follow in the footsteps of Luxturna™. However, despite promising results in preclinical...